GlassScriptPhysician profile
Jiaxin Tran
NPI 1710205042
$1,556.82
in general payments reported to CMS, 2019-2025
19 companies · $422 in 2025
The $422 reported for 2025 was more than what 75% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $194 · 2021: $43.49 · 2022: $227 · 2023: $314 · 2024: $209 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $369.37 | 2021-2025 | Botox |
| Ipsen Biopharmaceuticals, INC | $250.09 | 2019-2025 | Dysport |
| Coloplast Corp | $154.93 | 2022-2025 | Speedicath |
| Janssen Pharmaceuticals, INC | $144.87 | 2020-2022 | |
| Merz Pharmaceuticals, LLC | $137.61 | 2023-2025 | Xeomin |
| Allergan, INC. | $72.85 | 2019 | |
| Piramal Critical Care | $63.21 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $54.26 | 2022-2023 | Lyvispah |
| Dynasplint Systems INC. | $50.73 | 2025 | Dynasplint |
| Medtronic USA, INC. | $46.90 | 2019 | |
| Avanir Pharmaceuticals, INC. | $39.86 | 2021-2022 | |
| Merz North America, INC. | $32.74 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $27.28 | 2023-2024 | Gemtesa |
| Acadia Pharmaceuticals INC | $21.93 | 2023 | Daybue |
| Axsome Therapeutics, INC. | $19.73 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifeward, INC. | $19.40 | 2025 | |
| Metacel Pharmaceuticals LLC | $18.25 | 2022 | |
| Grt US Holding, INC. | $17.30 | 2021 | |
| Sunovion Pharmaceuticals INC. | $15.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiaxin Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.